4.2 Article

Plasma exchange-A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction

Related references

Note: Only part of the references are listed.
Article Hematology

Further evidence for the benefit of therapeutic plasma exchange for acute multi-organ failure syndrome refractory to red cell exchange in sickle cell disease

Raheel S. Siddiqui et al.

Summary: Therapeutic plasma exchange (TPE) has shown efficacy in treating MOFS in SCD patients, leading to clinical improvements and reduced mortality rates. There is evidence supporting the inclusion of MOFS secondary to acute SCD as an indication for TPE treatment.

JOURNAL OF CLINICAL APHERESIS (2021)

Review Critical Care Medicine

Reversal of Severe Multiorgan Failure Associated With Sickle Cell Crisis Using Plasma Exchange: A Case Series

Gulrukh Z. Zaidi et al.

JOURNAL OF INTENSIVE CARE MEDICINE (2020)

Article Education, Scientific Disciplines

Sickle cell disease: when and how to transfuse

Jo Howard

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)

Article Hematology

Nucleosomes and neutrophil activation in sickle cell disease painful crisis

Marein Schimmel et al.

HAEMATOLOGICA (2013)

Article Pathology

Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload

Francesca Vinchi et al.

AMERICAN JOURNAL OF PATHOLOGY (2008)

Article Hematology

Plasma exchange in critically ill patients with sickle cell disease

C. Boga et al.

TRANSFUSION AND APHERESIS SCIENCE (2007)

Article Critical Care Medicine

Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial

R Busund et al.

INTENSIVE CARE MEDICINE (2002)